Authors: RAFI I BODDY AV CALVETE JA TAYLOR GA NEWELL DR BAILEY NP LIND MJ GREEN M HINES J JOHNSTONE A CLENDENINN N CALVERT AH

Citation: I. Rafi et al., PRECLINICAL AND PHASE-I CLINICAL-STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR NOLATREXED DIHYDROCHLORIDE GIVEN BY PROLONGED ADMINISTRATION IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 16(3), 1998, pp. 1131-1141

Authors: RAFI I TAYLOR GA CALVETE JA BODDY AV BALMANNO K BAILEY N LIND M CALVERT AH WEBBER S JACKSON RC JOHNSTON A CLENDENINN N NEWELL DR

Citation: I. Rafi et al., CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR AMINO-6-METHYL-4-OXO-5-(4-PYRIDPLTHIO)-QUINAZOLONE DIHYDROCHLORIDE (AG337) GIVEN BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Clinical cancer research, 1(11), 1995, pp. 1275-1284

Authors: CALVETE JA NEWELL DR WRIGHT AF ROSE MS

Citation: Ja. Calvete et al., IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF ZENECA ZD0490, A RECOMBINANT RICIN A-CHAIN IMMUNOTOXIN FOR THE TREATMENT OF COLORECTAL-CANCER, Cancer research, 54(17), 1994, pp. 4684-4690

Authors: CALVETE JA NEWELL DR CHARLTON CJ WRIGHT AF

Citation: Ja. Calvete et al., PHARMACOKINETIC STUDIES IN MICE WITH ICI D0490, A NOVEL RECOMBINANT RICIN A-CHAIN IMMUNOTOXIN, British Journal of Cancer, 67(6), 1993, pp. 1310-1315